US5399363A
(en)
|
1991-01-25 |
1995-03-21 |
Eastman Kodak Company |
Surface modified anticancer nanoparticles
|
US6749868B1
(en)
|
1993-02-22 |
2004-06-15 |
American Bioscience, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
US5994341A
(en)
|
1993-07-19 |
1999-11-30 |
Angiogenesis Technologies, Inc. |
Anti-angiogenic Compositions and methods for the treatment of arthritis
|
GB9413202D0
(en)
|
1994-06-30 |
1994-08-24 |
Univ Bradford |
Method and apparatus for the formation of particles
|
US5626862A
(en)
|
1994-08-02 |
1997-05-06 |
Massachusetts Institute Of Technology |
Controlled local delivery of chemotherapeutic agents for treating solid tumors
|
US5874481A
(en)
|
1995-06-07 |
1999-02-23 |
Alliance Pharmaceutical Corp. |
Fluorochemical solutions for the delivery of lipophilic pharmaceutical agents
|
US5833891A
(en)
|
1996-10-09 |
1998-11-10 |
The University Of Kansas |
Methods for a particle precipitation and coating using near-critical and supercritical antisolvents
|
US5874029A
(en)
|
1996-10-09 |
1999-02-23 |
The University Of Kansas |
Methods for particle micronization and nanonization by recrystallization from organic solutions sprayed into a compressed antisolvent
|
US6495579B1
(en)
|
1996-12-02 |
2002-12-17 |
Angiotech Pharmaceuticals, Inc. |
Method for treating multiple sclerosis
|
DE69737510T2
(de)
|
1996-12-30 |
2007-12-06 |
Battelle Memorial Institute, Columbus |
Verwendung eines unverkapselten Antikrebs-Arzneimittels zur Herstellung einer Zubereitung zur Behandlung von Neoplasmen durch Inhalation
|
SG165156A1
(en)
*
|
1997-06-27 |
2010-10-28 |
Abraxis Bioscience Llc |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
CN100462066C
(zh)
|
1997-06-27 |
2009-02-18 |
美国生物科学有限公司 |
药剂的新制剂及其制备和应用方法
|
US6117949A
(en)
|
1998-10-01 |
2000-09-12 |
Macromed, Inc. |
Biodegradable low molecular weight triblock poly (lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
|
JP3418751B2
(ja)
|
1998-01-22 |
2003-06-23 |
参天製薬株式会社 |
フルオロメトロン懸濁型点眼剤
|
IL131217A0
(en)
|
1998-03-10 |
2001-01-28 |
Napro Biotherapeutics Inc |
Novel methods and compositions for delivery of taxanes
|
US6221153B1
(en)
|
1998-06-09 |
2001-04-24 |
Trevor Percival Castor |
Method for producing large crystals of complex molecules
|
US7521068B2
(en)
|
1998-11-12 |
2009-04-21 |
Elan Pharma International Ltd. |
Dry powder aerosols of nanoparticulate drugs
|
US6113795A
(en)
|
1998-11-17 |
2000-09-05 |
The University Of Kansas |
Process and apparatus for size selective separation of micro- and nano-particles
|
AU1556800A
(en)
|
1998-11-25 |
2000-06-13 |
Universitatsklinikum Freiburg |
Hyperforin as cytostatic agent and hyperforin ointment or cream as application form
|
US6537585B1
(en)
|
1999-03-26 |
2003-03-25 |
Guilford Pharmaceuticals, Inc. |
Methods and compositions for treating solid tumors
|
US7217735B1
(en)
|
1999-04-09 |
2007-05-15 |
Au Jessie L-S |
Methods and compositions for enhancing delivery of therapeutic agents to tissues
|
US6610317B2
(en)
|
1999-05-27 |
2003-08-26 |
Acusphere, Inc. |
Porous paclitaxel matrices and methods of manufacture thereof
|
BR0010984A
(pt)
|
1999-05-27 |
2002-04-30 |
Acusphere Inc |
Matrizes porosas de medicamento e processos para fabricação das mesmas
|
US6858199B1
(en)
|
2000-06-09 |
2005-02-22 |
Advanced Inhalation Research, Inc. |
High efficient delivery of a large therapeutic mass aerosol
|
US6616849B1
(en)
|
1999-08-25 |
2003-09-09 |
Shimadzu Corporation |
Method of and system for continuously processing liquid materials, and the product processed thereby
|
JP2003513756A
(ja)
|
1999-11-12 |
2003-04-15 |
アンジオテック ファーマシューティカルズ,インコーポレイテッド |
放射性治療と細胞周期インヒビターとの組合せの組成物
|
US6620351B2
(en)
|
2000-05-24 |
2003-09-16 |
Auburn University |
Method of forming nanoparticles and microparticles of controllable size using supercritical fluids with enhanced mass transfer
|
US6562952B1
(en)
|
2000-10-31 |
2003-05-13 |
The University Of Kansas |
Precipitation of proteins from organic solutions
|
US20020081339A1
(en)
|
2000-12-22 |
2002-06-27 |
Philippe Menei |
Treatment of inoperable tumors by stereotactic injection of microspheres
|
CA2445763A1
(en)
|
2001-05-01 |
2002-11-07 |
Angiotech Pharmaceuticals Inc. |
Compositions comprising an anti-microtubule agent and a polypeptide or a polysaccharide and the use thereof for the preparation of a medicament for the treatment of inflammatory conditions
|
WO2003004142A1
(en)
|
2001-07-02 |
2003-01-16 |
Micro & Nano Materials Sagl |
Process for the production of micro and/or nano particles
|
US20030054042A1
(en)
|
2001-09-14 |
2003-03-20 |
Elaine Liversidge |
Stabilization of chemical compounds using nanoparticulate formulations
|
US20030134810A1
(en)
*
|
2001-10-09 |
2003-07-17 |
Chris Springate |
Methods and compositions comprising biocompatible materials useful for the administration of therapeutic agents
|
WO2003032906A2
(en)
|
2001-10-15 |
2003-04-24 |
Crititech, Inc. |
Delivery of poorly soluble drugs
|
AU2002364701B8
(en)
|
2001-11-20 |
2006-06-22 |
Alkermes, Inc. |
Compositions for sustained action product delivery
|
AU2003217950A1
(en)
|
2002-03-05 |
2003-09-22 |
Cleveland State University |
Agglomerated particles for aerosol drug delivery
|
JP4842514B2
(ja)
|
2002-03-20 |
2011-12-21 |
エラン ファーマ インターナショナル,リミティド |
血管新生抑制剤のナノ粒子組成物
|
CA2483218C
(en)
|
2002-04-25 |
2012-07-10 |
Nektar Therapeutics Uk Ltd |
Particulate materials
|
CA2482941A1
(en)
|
2002-04-26 |
2003-11-06 |
Teva Pharmaceutical Industries Ltd. |
Microparticle pharmaceutical compositions for intratumoral delivery
|
US9339459B2
(en)
|
2003-04-24 |
2016-05-17 |
Nektar Therapeutics |
Particulate materials
|
CN1255394C
(zh)
|
2002-06-24 |
2006-05-10 |
成都思摩纳米技术有限公司 |
紫杉醇纳米微粒的制备方法及应用
|
KR100573289B1
(ko)
|
2002-07-20 |
2006-04-24 |
대화제약 주식회사 |
방광내 투여를 통한 방광암치료용 파클리탁셀 조성물 및그의 제조 방법
|
WO2004098570A1
(en)
|
2002-10-30 |
2004-11-18 |
Spherics, Inc. |
Nanoparticulate bioactive agents
|
KR100508518B1
(ko)
|
2002-11-13 |
2005-08-17 |
한미약품 주식회사 |
초임계유체 공정을 이용한 파클리탁셀 고체분산체의 제조방법 및 이 방법으로 제조된 파클리탁셀 고체분산체
|
ES2685436T3
(es)
|
2002-12-09 |
2018-10-09 |
Abraxis Bioscience, Llc |
Composiciones y procedimientos para administración de agentes farmacológicos
|
US7455797B2
(en)
|
2003-02-28 |
2008-11-25 |
Ferro Corporation |
Method and apparatus for producing particles using supercritical fluid
|
AU2004228008B2
(en)
|
2003-04-03 |
2008-11-06 |
Jessie L.-S. Au |
Tumor-targeting drug-loaded particles
|
US20060147535A1
(en)
|
2003-04-16 |
2006-07-06 |
Poongunran Muthukumaran |
Methods for and compositions of anticancer medicaments
|
US20050059613A1
(en)
|
2003-07-08 |
2005-03-17 |
Bahram Memarzadeh |
Compositions and methods for the enhanced uptake of therapeutic agents through the bladder epithelium
|
US8021831B2
(en)
|
2003-08-25 |
2011-09-20 |
Board Of Regents, The University Of Texas System |
Taxane chemosensitivity prediction test
|
JP2007001865A
(ja)
|
2003-09-16 |
2007-01-11 |
Ltt Bio-Pharma Co Ltd |
脂溶性薬物封入微粒子、その製造法およびそれを含有する製剤
|
JP5645340B2
(ja)
|
2003-10-15 |
2014-12-24 |
メディゲーネ アクチエンゲゼルシャフトMediGene AG |
活性成分を含有するカチオンリポソームの投与方法
|
US7208106B2
(en)
|
2003-10-24 |
2007-04-24 |
Ferro Corporation |
Method of forming particles
|
CA2544627A1
(en)
|
2003-11-05 |
2005-05-19 |
Elan Pharma International Ltd. |
Nanoparticulate compositions having a peptide as a surface stabilizer
|
GB0402963D0
(en)
|
2004-02-11 |
2004-03-17 |
Univ Nottingham |
Counter current mixing device for two different fluids
|
US8043631B2
(en)
|
2004-04-02 |
2011-10-25 |
Au Jessie L S |
Tumor targeting drug-loaded particles
|
EP1818093B1
(en)
|
2004-10-29 |
2014-03-12 |
Nara Machinery Co., Ltd. |
Method of granulating fine particles
|
EP1830813A2
(en)
|
2004-12-14 |
2007-09-12 |
Transave, Inc. |
Lipid particles comprising bioactive agents, methods of preparing and uses thereof
|
ES2265262B1
(es)
|
2005-01-31 |
2008-03-01 |
Activery Biotech, S.L.(Titular Al 50%) |
Procedimiento para la obtencion de sistemas micro- y nanodispersos.
|
US8735394B2
(en)
|
2005-02-18 |
2014-05-27 |
Abraxis Bioscience, Llc |
Combinations and modes of administration of therapeutic agents and combination therapy
|
WO2006091780A2
(en)
|
2005-02-24 |
2006-08-31 |
Elan Pharma International Limited |
Nanoparticulate formulations of docetaxel and analogues thereof
|
US7872050B2
(en)
|
2005-03-14 |
2011-01-18 |
Yaupon Therapeutics Inc. |
Stabilized compositions of volatile alkylating agents and methods of using thereof
|
PL1865924T3
(pl)
|
2005-03-31 |
2016-06-30 |
Lidds Ab |
Sposób leczenia chorób gruczołu krokowego oparty na miejscowym dostarczaniu substancji czynnych
|
CN1923189A
(zh)
|
2005-08-30 |
2007-03-07 |
孔庆忠 |
一种紫杉碱类抗癌药物的缓释注射剂
|
ES2719093T3
(es)
*
|
2005-08-31 |
2019-07-08 |
Abraxis Bioscience Llc |
Composiciones de fármacos poco solubles en agua con mayor estabilidad y métodos para su preparación
|
BRPI0619635A2
(pt)
|
2005-12-11 |
2011-10-04 |
Scf Technologies As |
produção de materiais de tamanho nano
|
US8906392B2
(en)
|
2005-12-16 |
2014-12-09 |
University Of Kansas |
Nanocluster compositions and methods
|
AR054215A1
(es)
|
2006-01-20 |
2007-06-13 |
Eriochem Sa |
Una formulacion farmaceutica de un taxano, una composicion solida de un taxano liofilizado a partir de una solucion de acido acetico, un procedimiento para la preparacion de dicha composicion solida de un taxano, una composicion solubilizante de un taxano liofilizado, y un conjunto de elementos (kit
|
CN101336899A
(zh)
|
2006-01-25 |
2009-01-07 |
济南帅华医药科技有限公司 |
含紫杉烷的抗癌缓释注射剂
|
AU2007224651B8
(en)
|
2006-03-14 |
2011-10-27 |
Lidds Ab |
Bioresorbable controlled-release composition
|
ES2390183T3
(es)
|
2006-10-11 |
2012-11-07 |
Crititech, Inc. |
Método de precipitación de partículas pequeñas de medicamento en recipiente de uso
|
TWI405590B
(zh)
|
2007-04-06 |
2013-08-21 |
Activus Pharma Co Ltd |
微粉碎化有機化合物粒子之製法
|
EP2146707A2
(en)
|
2007-05-03 |
2010-01-27 |
Abraxis BioScience, LLC |
Methods and compositions for treating pulmonary hypertension
|
WO2009006590A2
(en)
|
2007-07-04 |
2009-01-08 |
Dr. Reddy's Laboratories Ltd. |
Docetaxel process and polymorphs
|
CN101129338A
(zh)
|
2007-08-27 |
2008-02-27 |
四川大学 |
超临界流体新技术微细化抗癌药物紫杉醇
|
AU2009222230A1
(en)
|
2008-03-06 |
2009-09-11 |
Nitto Denko Corporation |
Polymer paclitaxel conjugates and methods for treating cancer
|
CA2737543C
(en)
|
2008-09-19 |
2015-01-06 |
Activus Pharma Co., Ltd. |
Composite organic compound powder for medical use and production method and suspension of the same
|
US20110293672A1
(en)
|
2008-12-02 |
2011-12-01 |
Biocompatibles Uk Limited |
Pancreatic tumour treatment
|
PT104693B
(pt)
|
2009-07-27 |
2011-11-24 |
Univ Lisboa |
Nanopartículas lipídicas semi-sólidas contendo um agente antineoplásico e seu processo de preparação
|
EP3854870A1
(en)
|
2009-08-24 |
2021-07-28 |
Baylor College of Medicine |
Generation of ctl lines with specificity against multiple tumor antigens or multiple viruses
|
CN101829061A
(zh)
|
2010-05-14 |
2010-09-15 |
无锡纳生生物科技有限公司 |
一种紫杉醇纳米颗粒组合物及其制备方法
|
MX343671B
(es)
|
2010-06-02 |
2016-11-16 |
Abraxis Bioscience Llc * |
Metodos de tratamiento de cancer de vejiga.
|
CA2811869A1
(en)
|
2010-09-21 |
2012-03-29 |
Cristal Delivery B.V. |
Tunable, biodegradable linker molecules for transient conjugation of components in drug delivery systems, and drug delivery systems prepared therewith
|
JP2014504260A
(ja)
|
2010-10-15 |
2014-02-20 |
グラクソ グループ リミテッド |
集合ナノ粒子状薬物製剤、その製造及び使用
|
US20120177910A1
(en)
|
2011-01-11 |
2012-07-12 |
Boston Scientific Scimed, Inc. |
Coated Medical Devices
|
KR20140022904A
(ko)
|
2011-04-20 |
2014-02-25 |
유니버시티 오브 시드니 |
치료방법 및 그에 사용가능한 제제
|
WO2013052158A2
(en)
|
2011-04-26 |
2013-04-11 |
William Marsh Rice University |
Targeted nanovectors and their use for treatment of brain tumors
|
JP5932993B2
(ja)
|
2011-06-17 |
2016-06-08 |
バーグ エルエルシー |
吸入可能な医薬組成物
|
JP6162112B2
(ja)
|
2011-06-27 |
2017-07-12 |
クリスタル・デリバリー・ビー・ブイ |
制御された放出システム
|
FR2980683B1
(fr)
|
2011-09-30 |
2014-11-21 |
Univ Paris Curie |
Dispositif de guidage d'un instrument medical insere dans une voie naturelle ou une voie artificielle d'un patient
|
CN102488682A
(zh)
|
2011-11-22 |
2012-06-13 |
四川九章生物化工科技发展有限公司 |
绿原酸的抗癌新用途
|
WO2013166487A1
(en)
|
2012-05-04 |
2013-11-07 |
Yale University |
Highly penetrative nanocarriers for treatment of cns disease
|
TW201408304A
(zh)
|
2012-08-31 |
2014-03-01 |
Cathay General Hospital |
一種合併抗癌藥物及荷爾蒙之抗腎細胞癌藥物及其製造方法
|
US9511046B2
(en)
|
2013-01-11 |
2016-12-06 |
Abraxis Bioscience, Llc |
Methods of treating pancreatic cancer
|
KR101695580B1
(ko)
|
2013-02-28 |
2017-01-13 |
화이자 인코포레이티드 |
증가된 안정성의 신규한 액체 조성물
|
US9925512B2
(en)
|
2013-03-14 |
2018-03-27 |
Crititech, Inc. |
Equipment assembly for and method of processing particles
|
US8778181B1
(en)
|
2013-03-14 |
2014-07-15 |
Crititech, Inc. |
Equipment assembly for and method of processing particles
|
WO2014155146A1
(en)
|
2013-03-28 |
2014-10-02 |
Bbs Nanotechnology Llc |
Stable nanocomposition comprising paclitaxel, process for the preparation thereof, its use and pharmaceutical compositions containing it
|
WO2014169137A1
(en)
|
2013-04-10 |
2014-10-16 |
Massachusetts Institute Of Technology |
Local drug delivery devices and methods for treating cancer
|
US10188738B2
(en)
|
2013-10-16 |
2019-01-29 |
Université Libre de Bruxelles |
Formulations useful in the treatment of proliferative diseases affecting the respiratory tract
|
HUE047699T2
(hu)
|
2013-12-17 |
2020-05-28 |
Hoffmann La Roche |
Eljárások rákbetegségek kezelésére PD-1-tengelyhez kötõdõ antagonisták és taxánok alkalmazásával
|
WO2015095811A2
(en)
|
2013-12-20 |
2015-06-25 |
The Board Institute Inc. |
Combination therapy with neoantigen vaccine
|
WO2015103005A1
(en)
*
|
2014-01-03 |
2015-07-09 |
Research Institute At Nationwide Children's Hospital |
Amphiphilic amine compounds and their use as therapeutic agents and nanocarriers
|
TWI601542B
(zh)
|
2014-04-18 |
2017-10-11 |
林信湧 |
一種用於治療肺癌之吸入式醫藥組成物及其備製方法
|
WO2015187194A1
(en)
|
2014-06-01 |
2015-12-10 |
Crititech, Inc. |
Use of paclitaxel particles
|
WO2015191590A2
(en)
|
2014-06-09 |
2015-12-17 |
Biomed Valley Discoveries, Inc. |
Combination therapies targeting tumor-associated stroma or tumor cells and microtubules
|
US10975442B2
(en)
|
2014-12-19 |
2021-04-13 |
Massachusetts Institute Of Technology |
Molecular biomarkers for cancer immunotherapy
|
KR102551708B1
(ko)
|
2015-06-04 |
2023-07-06 |
크리티테크, 인크. |
수집 장치 및 사용 방법
|
CN114588270A
(zh)
|
2015-09-16 |
2022-06-07 |
Dfb索里亚有限责任公司 |
包含紫杉烷类纳米颗粒的组合物及其用途
|
JP6877049B2
(ja)
*
|
2015-09-25 |
2021-05-26 |
ゼットワイ セラピューティクス インク.Zy Therapeutics Inc. |
多糖類−ビタミン共役体を含む粒状物に基づく薬物製剤
|
DE202016006620U1
(de)
|
2015-10-28 |
2017-04-12 |
Qass Gmbh |
Vorrichtungen zum Beobachten eines Magnetfelds eines Materialvolumens
|
WO2017127729A1
(en)
|
2016-01-20 |
2017-07-27 |
Fate Therapeutics, Inc. |
Compositions and methods for immune cell modulation in adoptive immunotherapies
|
KR20230017354A
(ko)
|
2016-04-04 |
2023-02-03 |
크리티테크, 인크. |
고형 종양의 치료 방법
|
CN107281502B
(zh)
|
2016-04-05 |
2021-05-04 |
上海市肿瘤研究所 |
一种复合显影温敏凝胶栓塞剂、制备方法及其应用
|
WO2017178585A1
(en)
|
2016-04-15 |
2017-10-19 |
Cellectis |
A method of engineering drug-specific hypersensitive t-cells for immunotherapy by gene inactivation
|
US9567399B1
(en)
|
2016-06-20 |
2017-02-14 |
Kymab Limited |
Antibodies and immunocytokines
|
EP4177271A1
(en)
|
2016-09-01 |
2023-05-10 |
Mayo Foundation for Medical Education and Research |
Carrier-pd-l1 binding agent compositions for treating cancers
|
JP2020514359A
(ja)
|
2017-03-15 |
2020-05-21 |
ディーエフビー ソリア リミテッド ライアビリティ カンパニー |
タキサンのナノ粒子を用いる皮膚悪性腫瘍処置のための局所療法
|
WO2018170207A1
(en)
|
2017-03-15 |
2018-09-20 |
Dfb Soria, Llc |
Topical therapy for the treatment of skin keratoses using nanoparticles of taxanes
|
WO2018170210A1
(en)
|
2017-03-15 |
2018-09-20 |
Dfb Soria, Llc |
Topical therapy for the treatment of vulvar intraepithelial neoplasia (vin) and genital warts using nanoparticles of taxanes
|
WO2018227037A1
(en)
|
2017-06-09 |
2018-12-13 |
Crititech, Inc. |
Treatment of epithelial cysts by intracystic injection of antineoplastic particles
|
SG10201913400QA
(en)
|
2017-06-14 |
2020-03-30 |
Crititech Inc |
Methods for treating lung disorders
|